Many share valuable insights, spotlight emerging therapies, and build community around chronic disease management
BPC-157 - , ,
Related: Who May Be at Higher Risk Higher-risk individuals may include: patients with prior GI disorders individuals prone to dehydration people with kidney disease patients with diabetes-related vascular disease older adults long-term GLP-1 users Saxenda and Lawsuits Saxenda is included in broader GLP-1 litigation , particularly claims involving: severe motility disorders kidney injury gallbladder surgery pancreatitis permanent digestive injury blindness / NAION Saxenda lawsuits hub: Lawsuits When to Consider a Review You may want to consider review if: you used Saxenda, AND you required ER care or hospitalization, OR you developed a diagnosed complication, OR symptoms persisted after stopping the drug Start here: File a Claim Saxenda is an established weight-loss GLP-1 medication that can help reduce appetite and body weight, but it may also cause serious and persistent side effects in some patients

Chartered Trading Standards Institute (CTSI) The Chartered Trading Standards Institute (CTSI) is a national not for profit established in 1881 which supports the UKs trading standards profession, and works to protect consumers and honest businesses
It belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists , which mimic the action of a naturally occurring hormone in the body
While most modern diets contain plenty of omega-6, they often lack GLA specifically